Retagliptin

Intermediates - Retagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor developed for the treatment of type 2 diabetes by increasing incretin levels to improve insulin secretion and blood glucose control. Reference standards of Retagliptin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Retagliptin
    [catalogue_number] => PA 18 1850000
    [category_ids] => ,82,80,78,71,70,
    [chemical_name] => 
    [weight] => 464.37
    [form] => C19H18F6N4O3
    [cas] => 1174122-54-3
    [pslug] => 1174122-54-3-retagliptin-pa181850000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 18 1850000
PA 18 1850000

Retagliptin


  • Catalogue No.:PA 18 1850000

  • CAS :

    1174122-54-3

  • Molecular Formula : C19H18F6N4O3

  • Molecular Weight : 464.37

pharmaffiliates